Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency  | Penalty Amount |
|---|---|---|---|---|---|---|
| GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
| IMO SANOFI PASTEUR | Sanofi | pharmaceuticals | hazardous waste violation | 2014 | EPA | $77,643 |
| NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2016 | EPA | $8,400 |
| VERSUM MATERIALS, INC. | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2020 | EPA | $17,600 |
| MERCK SHARP & DOHME CORP. | Merck | pharmaceuticals | hazardous waste violation | 2023 | EPA | $6,250 |
| EM INDUSTRIES, INC. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| UCB CHEMICAL CORPORATION | UCB | pharmaceuticals | environmental violation | 2001 | EPA | $6,824 |
| MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
| KING PHARMACEUTICALS | Pfizer | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | pharmaceuticals | environmental violation | 2007 | EPA | $40,950 |
| ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
| LAFAYETTE PHARMACEUTICALS, INC. | Mallinckrodt | pharmaceuticals | environmental violation | 2001 | EPA | $17,600 |
| ALPHARMA, INC. | Zoetis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| PHIBRO-TECH, INC. | Phibro Animal Health | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| research organics | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2003 | EPA | $159,672 |
| PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
| ABBOTT LABS-N CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2004 | EPA | $162,595 |
| Pharmacia & Upjohn Company | Pfizer | pharmaceuticals | air pollution violation | 2005 | EPA | $676,250 |
| Novartis Animal Health US, Inc. | Eli Lilly | pharmaceuticals | environmental violation | 2006 | EPA | $6,500 |
| ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2006 | EPA | $475,672 |
| Alpharma Inc. (Chicago Heights) | Zoetis | pharmaceuticals | environmental violation | 2006 | EPA | $29,737 |
| ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $337,500 |
| Phibro-Tech, Inc. | Phibro Animal Health | pharmaceuticals | hazardous waste violation | 2008 | EPA | $151,603 |
| ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | air pollution violation | 2009 | EPA | $12,000 |
| ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2011 | EPA | $135,756 |
| CSL Behring LLC | CSL Limited | pharmaceuticals | air pollution violation | 2015 | EPA | $62,780 |
| ACTAVIS,INC. | AbbVie | pharmaceuticals | hazardous waste violation | 2015 | EPA | $30,800 |
| Pharmacia and Upjohn Company LLC | Pfizer | pharmaceuticals | environmental violation | 2017 | EPA | $34,170 |
| Aldrich Chemical | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2018 | EPA | $5,000 |
| Aldrich Chemical, LLC | Merck KGaA (EMD) | pharmaceuticals | hazardous waste violation | 2018 | EPA | $5,000 |
| KREMERS URBAN PHARMACEUTICALS INC | Lannett Co. | pharmaceuticals | air pollution violation | 2018 | EPA | $285,000 |
| CSL BEHRING LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
| MALLINCKRODT, INC | Mallinckrodt | pharmaceuticals | air pollution violation | 2004 | EPA | $80,160 |
| CAMBREX CHARLES CITY, INC | Cambrex | pharmaceuticals | hazardous waste violation | 2006 | EPA | $106,749 |
| SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | pharmaceuticals | air pollution violation | 2007 | EPA | $55,000 |
| ABBOTT LABORATORIES | Abbott Laboratories | pharmaceuticals | hazardous waste violation | 2008 | EPA | $25,033 |
| TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $900,000 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
| MALLINCKRODT, LLC | Mallinckrodt | pharmaceuticals | hazardous waste violation | 2013 | EPA | $449,740 |
| GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
| DePuy Synthes | Johnson & Johnson | pharmaceuticals | hazardous waste violation | 2019 | EPA | $51,750 |
| Amgen Inc. | Amgen | pharmaceuticals | hazardous waste violation | 2007 | EPA | $24,368 |
| Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
| Genentech | Roche | pharmaceuticals | environmental violation | 2023 | EPA | $158,209 |
| Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
| NOVARTIS PRODUCTS | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $13,200 |
| NOVARTIS CONSUMER HEALTH, INC. | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
| ETHICON ENDO SURGERY | Johnson & Johnson | pharmaceuticals | aviation safety violation | 2010 | FAA | $5,500 |
| ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $6,500 |
| MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $15,000 |
| SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2011 | FAA | $30,000 |
| SIGMA-ALDRICH INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $8,000 |
| SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2013 | FAA | $11,000 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | pharmaceuticals | aviation safety violation | 2014 | FAA | $15,000 |
| GLAXO SMITH KLINE | GlaxoSmithKline | pharmaceuticals | aviation safety violation | 2014 | FAA | $59,500 |
| ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2016 | FAA | $7,500 |
| MERCK & CO. | Merck | pharmaceuticals | aviation safety violation | 2015 | FAA | $65,000 |
| MERCK & CO. INC. | Merck | pharmaceuticals | aviation safety violation | 2015 | FAA | $65,000 |
| SIGMA-ALDRICH, INC | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2017 | FAA | $5,000 |
| Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
| Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
| Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
| UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
| Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
| Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
| Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
| Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
| GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
| Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
| Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | pharmaceuticals | campaign finance violation | 2007 | FEC | $9,000 |
| Astellas Pharma US, Inc. | Astellas Pharma | pharmaceuticals | campaign finance violation | 2022 | FEC | $7,500 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
| General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
| VISTAKON | Johnson & Johnson | pharmaceuticals | hazardous waste violation | 2005 | FL-DEP | $9,771 |
| ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | hazardous waste violation | 2001 | FL-DEP | $15,000 |
| CAMBRIDGE MAJOR LABORATORIES INC | Alcami | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
| EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $7,614 |
